Can Low Estrogen Cause UTI Symptoms With Negative Cultures?
At a Glance
Low estrogen after menopause can cause Genitourinary Syndrome of Menopause, leading to burning, urinary urgency, and frequent urination that mimic a UTI. A negative culture does not prove the cause; clinicians should assess for infection and other conditions before considering local vaginal estrogen.
Yes—low estrogen resulting in Genitourinary Syndrome of Menopause (GSM) is a common cause, though a negative culture does not by itself diagnose GSM. As estrogen levels decline during and after menopause, you can develop urinary urgency, frequency, and burning that feel exactly like a urinary tract infection (UTI) [1][2]. This happens because the tissues of your urinary tract rely on estrogen to stay thick, elastic, and healthy. When estrogen falls, these tissues thin out and become easily irritated [3].
Why Low Estrogen Mimics a UTI
The lower urinary tract—specifically the urethra (the tube that carries urine out) and the base of the bladder (the trigone)—is rich in estrogen receptors [4][1]. These tissues need steady estrogen to function normally.
When menopause causes estrogen levels to decline, the urinary and vaginal tissues experience a cluster of changes known as Genitourinary Syndrome of Menopause (GSM) [5]. This lack of estrogen leads to:
- Tissue Thinning (Atrophy): The lining of the urethra and estrogen-responsive vulvovaginal tissues lose collagen, elastin, and thickness [3]. The thinned tissue becomes fragile and sensitive, causing burning and pain (dysuria) [2].
- Loss of Elasticity: As the tissues lose their stretch, the bladder can become irritated more easily, leading to a sudden, intense need to urinate (urgency) and needing to go more often (frequency) [3][6].
- Microbiome Shifts: Estrogen normally feeds healthy Lactobacillus bacteria in the vagina, which keep the environment slightly acidic. Without estrogen, the vaginal pH rises (becomes less acidic), the microbial community shifts, and the area becomes more vulnerable to irritation and bacterial infections [7][8].
Because burning, urgency, and frequency overlap so closely with the symptoms of a bacterial infection, it is very common to mistake a GSM flare for a UTI [9][2].
Interpreting Negative Cultures and Other Causes
If you feel like you have a UTI, a clinician will likely request a urine culture to check for bacterial growth. In one large study of postmenopausal women with UTI-like symptoms, nearly 40% of completed urine cultures came back negative [9].
However, a negative culture does not automatically prove you have GSM. Cultures can sometimes be falsely negative if you started antibiotics before providing the sample, or if the bacterial count was low. Persistent or negative-culture symptoms also require considering other conditions, such as overactive bladder, pelvic-floor dysfunction, interstitial cystitis (bladder pain syndrome), sexually transmitted infections, or kidney stones [10][11].
When to Seek Urgent Care
Do not assume all urinary symptoms are just low estrogen. Seek prompt medical assessment if you experience fever, chills, back or flank pain, vomiting, visible blood in your urine, inability to urinate, or severe, worsening pain.
The Challenge of Repeated Antibiotics
Because symptoms are so similar, many women with GSM are repeatedly prescribed antibiotics while waiting for culture results—or even after a negative culture [9].
Taking antibiotics when they aren’t needed does not treat the root cause of estrogen-deprived tissue. Furthermore, unnecessary antibiotic use can disrupt your gut and vaginal microbiome, cause yeast infections, and increase your risk of developing antibiotic-resistant bacteria [12].
Important: Never stop a prescribed antibiotic on your own, even if a culture comes back negative. Always contact your clinician for guidance, as they interpret the culture alongside your history and urinalysis.
An Evidence-Based Option: Local Estrogen Therapy
If your clinician determines your recurrent symptoms are caused by GSM, low-dose local (vaginal) estrogen is an evidence-based option [13][8]. For mild dryness, non-hormonal vaginal moisturizers and lubricants can help, but for urinary symptoms, estrogen is often more targeted to the underlying tissue changes [14].
Local (vaginal) estrogen comes in low-dose creams, dissolving inserts, or flexible rings placed in the vagina. This therapy works by:
- Improving the health, thickness, and elasticity of estrogen-responsive vulvovaginal and urethral tissues [3][15].
- Restoring a healthy, acidic vaginal pH and encouraging protective Lactobacillus bacteria to return [16][12].
- Reducing the burning, urgency, and frequency associated with GSM [13].
- Decreasing the risk of recurrent, confirmed bacterial UTIs [17][18].
Safety and Timeline:
Local estrogen usually results in low systemic absorption [14][19]. However, it is not appropriate for everyone. You should discuss this option carefully with your clinician—and your oncology team, if applicable—if you have unexplained vaginal bleeding, or a history of breast or endometrial cancer [20][21].
Additionally, unlike an antibiotic that can clear a bacterial infection in a few days, local estrogen needs time to work. It typically takes weeks to months of consistent use, following the specific instructions for your prescribed product, to see significant relief from urinary symptoms [22][18].
Common questions in this guide
Can menopause-related low estrogen cause burning and urgency even if my urine culture is negative?
Does a negative urine culture prove that I do not have a UTI?
How can I tell Genitourinary Syndrome of Menopause apart from a bacterial UTI?
Can vaginal estrogen help with UTI-like symptoms after menopause?
How long does local vaginal estrogen take to work for urinary symptoms?
When should urinary symptoms be treated as urgent?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
About testing
Should I have a urine culture to check for bacterial growth?
Treatment options
Would local (vaginal) estrogen be an option for my urinary symptoms?
Other possible causes
Could other conditions, like overactive bladder, be causing my symptoms?
Related questions
Get notified when new evidence is published on postmenopausal atrophic vaginitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (22)
- 1
Consensus statement - Urogenital atrophy.
Briggs P
Post reproductive health 2022; (28(1)):47-50 doi:10.1177/20533691211065808.
PMID: 35103527 - 2
Hormonal Approach for Postmenopausal Vulvovaginal Atrophy.
Costa APF, Sarmento ACA, Vieira-Baptista P, et al.
Frontiers in reproductive health 2021; (3()):783247 doi:10.3389/frph.2021.783247.
PMID: 36303971 - 3
Genitourinary syndrome of menopause treatment using lasers and temperature-controlled radiofrequency.
Wańczyk-Baszak J, Woźniak S, Milejski B, Paszkowski T
Przeglad menopauzalny = Menopause review 2018; (17(4)):180-184 doi:10.5114/pm.2018.81743.
PMID: 30766466 - 4
Treatment of the genitourinary syndrome of menopause.
Palacios S, Mejía A, Neyro JL
Climacteric : the journal of the International Menopause Society 2015; (18 Suppl 1()):23-9 doi:10.3109/13697137.2015.1079100.
PMID: 26366797 - 5
Vaginal Estrogen: Pearls for the Practitioner A Practical Review of Evidence, Guidelines, and Prescribing Strategies for Genitourinary Syndrome of Menopause.
Perelmuter S, Srivastava M, Freedman KP, et al.
Journal of women's health (2002) 2026; (35(10)):900-907 doi:10.1177/15409996261465193.
PMID: 42381200 - 6
Nocturia in Menopausal Women: The Link Between Two Common Problems of the Middle Age.
Pauwaert K, Goessaert AS, Robinson D, et al.
International urogynecology journal 2024; (35(5)):935-946 doi:10.1007/s00192-024-05743-1.
PMID: 38436669 - 7
Menopause, skin and common dermatosis. Part 3: genital disorders.
Musbahi E, Kamp E, Ashraf M, DeGiovanni C
Clinical and experimental dermatology 2022; (47(12)):2123-2129 doi:10.1111/ced.15400.
PMID: 36103137 - 8
Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause.
Buck ES, Lukas VA, Rubin RS
Urology 2021; (151()):31-36 doi:10.1016/j.urology.2020.05.058.
PMID: 32533967 - 9
Underdiagnosed and overmedicated: Investigating the management of urinary tract infection and vaginal estrogen use in a large cohort of postmenopausal women.
Nahum R, Machtinger R, Oberman B, et al.
Maturitas 2025; (205()):108806 doi:10.1016/j.maturitas.2025.108806.
PMID: 41406900 - 10
Deconstructing the genitourinary syndrome of menopause.
Vieira-Baptista P, Marchitelli C, Haefner HK, et al.
International urogynecology journal 2017; (28(5)):675-679 doi:10.1007/s00192-017-3295-6.
PMID: 28293790 - 11
Diagnosis, causes, and treatment of dyspareunia in postmenopausal women.
Streicher LF
Menopause (New York, N.Y.) 2023; (30(6)):635-649 doi:10.1097/GME.0000000000002179.
PMID: 37040586 - 12
Preventing urinary tract infections after menopause without antibiotics.
Caretto M, Giannini A, Russo E, Simoncini T
Maturitas 2017; (99()):43-46 doi:10.1016/j.maturitas.2017.02.004.
PMID: 28364867 - 13
Menopause hormone therapy and urinary symptoms: a systematic review.
Christmas MM, Iyer S, Daisy C, et al.
Menopause (New York, N.Y.) 2023; (30(6)):672-685 doi:10.1097/GME.0000000000002187.
PMID: 37192832 - 14
The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
Menopause (New York, N.Y.) 2020; (27(9)):976-992 doi:10.1097/GME.0000000000001609.
PMID: 32852449 - 15
The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause.
Kaufman MR, Ackerman AL, Amin KA, et al.
The Journal of urology 2025; (214(3)):242-250 doi:10.1097/JU.0000000000004589.
PMID: 40298120 - 16
Vulvovaginal estrogen therapy for urinary symptoms in postmenopausal women: a review and meta-analysis.
Porcari I, Uccella S, Casprini C, et al.
Climacteric : the journal of the International Menopause Society 2026; (29(1)):13-22 doi:10.1080/13697137.2025.2517138.
PMID: 40569036 - 17
Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials.
Chen YY, Su TH, Lau HH
International urogynecology journal 2021; (32(1)):17-25 doi:10.1007/s00192-020-04397-z.
PMID: 32564121 - 18
Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial.
Muiños Fernández N, Martínez Salamanca JI, Pardo González de Quevedo JI, et al.
Maturitas 2024; (190()):108128 doi:10.1016/j.maturitas.2024.108128.
PMID: 39388913 - 19
Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause : A Systematic Review.
Danan ER, Sowerby C, Ullman KE, et al.
Annals of internal medicine 2024; (177(10)):1400-1414 doi:10.7326/ANNALS-24-00610.
PMID: 39250810 - 20
Menopausal hormone therapy and breast cancer: risk and management.
Sanserino K
Current opinion in obstetrics & gynecology 2026; (38(2)):117-122 doi:10.1097/GCO.0000000000001094.
PMID: 41696755 - 21
Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy.
Sussman TA, Kruse ML, Thacker HL, Abraham J
Journal of oncology practice 2019; (15(7)):363-370 doi:10.1200/JOP.18.00710.
PMID: 31291563 - 22
Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
Caruso S, Cianci S, Amore FF, et al.
Menopause (New York, N.Y.) 2016; (23(1)):47-54 doi:10.1097/GME.0000000000000485.
PMID: 26079974
This page explains how low estrogen and Genitourinary Syndrome of Menopause may cause UTI-like symptoms for informational purposes only and does not constitute medical advice. Consult a clinician for persistent symptoms, negative cultures, urgent warning signs, or decisions about antibiotics and vaginal estrogen.